Unresectable malignant pleural mesothelioma
Showing 1 - 25 of 7,086
Previously Unresectable Malignant Pleural Mesothelioma Treated
Not yet recruiting
- Malignant Pleural Mesothelioma
- Unresectable Malignant Neoplasm
- Data collection
-
Brest, France
- +4 more
Mar 30, 2022
Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)
Active, not recruiting
- Malignant Pleural Mesothelioma
- Mesothelioma
- Cisplatin
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 5, 2023
Pleural Mesothelioma Trial in Guangzhou (Cadonilimab+Bevacizumab+Pemetrexed+Carboplatin)
Not yet recruiting
- Pleural Mesothelioma
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jul 3, 2023
Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma
Recruiting
- Mesothelioma, Malignant
-
Shinjuku-ku, Tokyo, JapanLocal Institution
Apr 5, 2022
Mesothelioma, Malignant Trial in China (Nivolumab, Ipilimumab, Pemetrexed)
Recruiting
- Mesothelioma, Malignant
- Nivolumab
- +4 more
-
Beijing, Beijing, China
- +25 more
Jan 17, 2023
Malignant Pleural Mesothelioma, Advanced, Malignant Pleural Mesothelioma, Unresectable Trial in Mexico City (Atezolizumab)
Withdrawn
- Malignant Pleural Mesothelioma, Advanced
- Malignant Pleural Mesothelioma, Unresectable
-
Mexico City, MexicoHealth Pharma Professional Research
May 11, 2021
Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)
Not yet recruiting
- Malignant Pleural Mesothelioma
- Gemcitabine
- supportive care
-
Cairo, EgyptAin Shams University Hospital
Dec 20, 2022
Malignant Pleural Mesothelioma Trial (Proton beam therapy)
Not yet recruiting
- Malignant Pleural Mesothelioma
- Proton beam therapy
- (no location specified)
Dec 14, 2022
Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in
Recruiting
- Malignant Pleural Mesothelioma, Advanced
- Oncolytic Adenovirus H101
- Programmed death receptor-1 inhibitor
-
Tianjin, Tianjin, ChinaTianjin Medical Unversity Second Hospital
Sep 2, 2023
To Determine Safety, Tolerability and Efficacy of ONCOS-102 in Combination With Chemo Trial in France, Spain (ONCOS-102,
Active, not recruiting
- To Determine Safety, Tolerability and Efficacy of ONCOS-102 in Combination With Chemotherapy
- ONCOS-102
- +2 more
-
Dijon, France
- +6 more
Oct 6, 2020
Unresectable Pleural Mesothelioma Trial in Worldwide (Volrustomig, Pemetrexed, Carboplatin)
Not yet recruiting
- Unresectable Pleural Mesothelioma
- Volrustomig
- +5 more
-
Duarte, California
- +133 more
Oct 18, 2023
Mesotheliomas Pleural Trial in Amsterdam (Pembrolizumab, Lenvatinib)
Recruiting
- Mesotheliomas Pleural
-
Amsterdam, Noord-Holland, NetherlandsAntoni van Leeuwenhoekziekenhuis (NKI-AVL)
Jan 13, 2023
Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,
Not yet recruiting
- Malignant Pleural Mesothelioma
- Dendritic cell vaccination
- +2 more
-
Edegem, Antwerp, Belgium
- +2 more
Feb 28, 2023
Malignant Pleural Effusion, Malignant Pleural Mesothelioma, Mesothelioma Trial in Leicester (RSO-021)
Recruiting
- Malignant Pleural Effusion
- +3 more
-
Leicester, United Kingdom
- +5 more
Oct 28, 2022
Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))
Completed
- Pleural Mesothelioma
- Cyclophosphamide
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
Malignant Pleural Mesothelioma Trial in United States (E-Nose testing, Research blood)
Recruiting
- Malignant Pleural Mesothelioma
- E-Nose testing
- Research blood
-
Basking Ridge, New Jersey
- +6 more
Sep 8, 2023
Ovarian Cancer, Epithelial, Gastric Cancer, GastroEsophageal Junction (GEJ) Cancer Trial in United Kingdom (NX-1607)
Recruiting
- Ovarian Cancer, Epithelial
- +14 more
-
Sutton, Surrey, United Kingdom
- +6 more
Jul 22, 2022
Malignant Pleural Mesothelioma Trial in United States (Pembrolizumab, IMPRINT)
Recruiting
- Malignant Pleural Mesothelioma
- Pembrolizumab
- IMPRINT
-
Basking Ridge, New Jersey
- +6 more
Jul 13, 2022
Pleural Mesothelioma Malignant Advanced Trial in Spain, Switzerland, United Kingdom (Pembrolizumab, Gemcitabine, Vinorelbine)
Completed
- Pleural Mesothelioma Malignant Advanced
- Pembrolizumab
- +2 more
-
Barcelona, Spain
- +14 more
Aug 23, 2022
Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,
Recruiting
- Advanced Bile Duct Carcinoma
- +33 more
- Cisplatin
- +2 more
-
Sacramento, California
- +6 more
Aug 11, 2022
Malignant Pleural Mesotheliomas (Mpm), Malignant Pleural Effusions (Mpe), Epithelial Tumors, Malignant Trial run by the National
Not yet recruiting
- Malignant Pleural Mesotheliomas (Mpm)
- +4 more
- Cytoreductive surgery
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Malignant Pleural Mesothelioma, Chemo Effect Trial in Cairo (hyperthermic intrathoracic chemo)
Recruiting
- Malignant Pleural Mesothelioma
- Chemotherapy Effect
- hyperthermic intrathoracic chemotherapy
-
Cairo, EgyptAin Shams University hospitals
Aug 18, 2022
Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)
Not yet recruiting
- Pleural Mesothelioma
- Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
-
Rozzano, MI, Italy
- +5 more
Nov 30, 2023
Mesothelioma, Pleural Mesothelioma Trial in United States (Durvalumab)
Active, not recruiting
- Mesothelioma
- Pleural Mesothelioma
-
La Jolla, California
- +19 more
Nov 10, 2021